Multi-Platform Approach to Genotyping
CGI provides high quality genotyping services for clinical trials, which adhere to stringent regulatory standards including GLP, CLIA, and GCP. Our strategy is to be “platform agnostic”, meaning that CGI is not dedicated to any one technology platform. The flexibility, scalability, and versatility, provided by a multi-platform approach, allow us to provide the best solution for a wide range of client needs. CGI’s scientific team works with clients to choose the clinically relevant genes and variants, providing them with customizable, attention-driven service.
Over the past 10 years, our portfolio has grown to over 400 validated, clinical genotyping assays. If an assay for a particular gene or polymorphism is not available, CGI has extensive experience in custom assay development and validation. To learn more about our capabilities, contact us for more information.
|Summary of Genotyping Services
||Available Genotyping Platforms